規格 | 目錄價格 | 上海 | 安徽 | 武漢 | 成都 | 北方 | 深圳 | 會員價格 | 數量 |
---|---|---|---|---|---|---|---|---|---|
5g | ¥ ????? | > 10 | > 10 | 1 | 1 | 2 | 1 | ¥ ????? | - + |
10g | ¥ ǒǒ??? | > 10 | > 10 | 1 | -- | 1 | 1 | ¥ ǒǒ??? | - + |
25g | ¥ ????? | > 10 | 4 | 2 | 1 | 2 | 1 | ¥ ????? | - + |
100g | ¥ ?????? | 3 | 1 | -- | -- | -- | -- | ¥ ?????? | - + |
500g | ¥ ū?????? | -- | -- | -- | -- | -- | -- | ¥ ū?????? | - + |
1000g | 請詢價 | -- | -- | -- | -- | -- | -- | -- | - + |
大貨 | 請詢價 | -- | -- | -- | -- | -- | -- | -- | - + |
產品編號
1173478
CAS 號
1689-89-0
中文名稱
4-羥基-3-碘-5-硝基芐腈
MDL 號
MFCD00070776
分子量
290.01
存儲條件
2-8°C, protect from light, stored under nitrogen
網頁展示純度為入庫指導純度值,各批次間存在一定差異,實際純度以收貨為準
熔點
136-139°C
沸點
280.1±40.0 °C at 760 mmHg
閃點
旋光
描述
TPSA
87.16
LogP
1.77668
H_Acceptors
4
H_Donors
1
Rotatable_Bonds
1
[1]. Jiang R, et al. Cannabidiol is a potent inhibitor of the catalytic activity of cytochrome P450 2C19. Drug Metab Pharmacokinet. 2013;28(4):332-8.
[2]. B Markus, et al. In vitro metabolism of aromatic nitriles. J Pharm Sci. 1994 Dec;83(12):1729-34.
[3]. B McKinstry, et al. Morphological response of triclabendazole-susceptible and triclabendazole-resistant isolates of Fasciola hepatica to treatment in vitro with nitroxynil (Trodax). Parasitol Res. 2009 Feb;104(3):645-55.
[4]. B McKinstry, et al. Ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo and in vitro drug treatment with nitroxynil (Trodax). Parasitol Res. 2007 Sep;101(4):929-41.
[5]. G W Hutchinson, et al. Efficacy of an injectable combination anthelmintic (nitroxynil+clorsulon+ivermectin) against early immature Fasciola hepatica compared to triclabendazole combination flukicides given orally or topically to cattle. Vet Parasitol. 2009 Jun 10;162(3-4):278-84.
警示圖
警示詞
Danger
危險申明
H301-H315-H317-H319-H335-H400
警告申明
P261-P273-P280
GHS 編碼
GHS06,GHS09
危險類別
6.1
UN 編碼
3439
包裝等級
Ⅲ
現貨供應
專業護航
售后無憂
品質保障
無需湊單